Wenbin Gu

机构：Chinese Academy of Sciences, Guangzhou Institutes of Biomedicine and Health, Cell Technology (China), State Key Laboratory of Respiratory Disease, University of Hong Kong

发表论文 5 篇 · 总被引 109 次 · h-index 4

代表论文

• Tumor-derived circulating exosomal miR-342-5p and miR-574-5p as promising diagnostic biomarkers for early-stage Lung Adenocarcinoma (2020 · International Journal of Medical Sciences · 被引 51)
• DNMT1 inhibition reprograms T cells to NK-like cells with potent antitumor activity (2025 · Science Immunology · 被引 23)
• The long noncoding RNA HOTAIRM1 controlled by AML1 enhances glucocorticoid resistance by activating RHOA/ROCK1 pathway through suppressing ARHGAP18 (2021 · Cell Death and Disease · 被引 19)
• Defining ortholog-specific UHRF1 inhibition by STELLA for cancer therapy (2025 · Nature Communications · 被引 16)
• Early Different Downstream Target of Glucocorticoid Receptor Contributing to Glucocorticoids Sensitivity in Kasumi-1 Cells (2016 · Blood)